Report: Younger women battling breast cancer face more aggressive diagnoses

May 3, 2017, RTI International

As the nation struggles with soaring health care costs, a new report by RTI International shows that younger women diagnosed with breast cancer face a significant treatment burden.

The report, published in Breast Cancer Research and Treatment, estimates the cost of breast cancer among women 45 years and younger.

"Younger women diagnosed with breast cancer often face more aggressive treatment, and are therefore more vulnerable to financial hardships," said Benjamin T. Allaire, report author and research economist at RTI. "This hardship leads some to forgo or delay necessary treatments, which may lead to immediate or future complications."

Analyzing data from the North Carolina Central Cancer Registry, report authors found that with private health insurance cost substantially more to treat than . Excess costs among women under the age of 45 enrolled in the registry for a year totaled $97,000, while older women had excess costs of $76,000. Younger women are more likely to be diagnosed with later stage cancers (Stages III and IV), and when they are, the excess costs to treat them are more than $132,000, compared to $124,000 for older women.

"Based on previous research, we knew that younger women cost more to treat than older women, but did not fully understand why," Allaire said. "Our new research reveals that it is because they are diagnosed with later stage cancers and they require more intense treatment. The magnitude of these costs underscores the importance of maintaining insurance coverage."

The report concludes that more research is needed to explore the drivers of cost differences and the impact of higher costs on the quality of life for younger survivors.

Explore further: Different breast cancer treatment options vary widely in their cost-effectiveness

Related Stories

Different breast cancer treatment options vary widely in their cost-effectiveness

April 10, 2017
A new study published today in the Journal of the National Cancer Institute indicates that different therapies for early-stage breast cancer have very different relative values. Some therapies may have fewer complications ...

Younger breast cancer survivors face bigger hurdles

February 1, 2016
Breast cancer takes a daunting toll on all women, but it hits younger women especially hard, finds a new study from the Brown School at Washington University in St. Louis.

Researchers identify breast cancer risk factors for younger, black women

October 19, 2016
Black women under the age of 45 are at increased risk for an aggressive form of breast cancer [estrogen receptor (ER) negative] if they experienced a high number of pregnancies, never breast fed, and/or had higher waist-to-hip ...

Older women may not be offered breast reconstruction after mastectomy

February 8, 2017
A national study from England indicates that older women are often not offered immediate breast reconstruction following a mastectomy, even though guidelines state that surgeons should discuss reconstruction with all suitable ...

Racial differences in male breast cancer outcomes

May 4, 2015
While black and white men under age 65 diagnosed with early-stage breast cancer received similar treatment, blacks had a 76% higher risk of death than whites, according to a new study. The study, published in the Journal ...

Mastectomy and reconstruction has higher complication rates, costs than lumpectomy and radiation

December 10, 2015
Among the various guideline-concordant local therapy options available for women with early-stage breast cancer in the United States, mastectomy plus reconstruction had the highest complication rates and complication-related ...

Recommended for you

From the ashes of a failed pain drug, a new therapeutic path emerges

November 16, 2018
In 2013, renowned Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, Ph.D., and chemist Kai Johnsson, Ph.D., his fellow co-founder at Quartet Medicine, believed they held the key to non-narcotic pain relief. ...

Repurposing FDA-approved drugs can help fight back breast cancer

November 16, 2018
Screening Food and Drug Administration (FDA)-approved compounds for their ability to stop cancer growth in the lab led to the finding that the drug flunarizine can slow down the growth of triple-negative breast cancer in ...

Traditional chemotherapy superior to new alternative for oropharyngeal cancers

November 16, 2018
A drug increasingly used in combination with radiotherapy to treat a type of cancer that forms in the tonsils or the base of the tongue is inferior to a previously favored option, according to a large, clinical trial led ...

New 'SLICE' tool can massively expand immune system's cancer-fighting repertoire

November 15, 2018
Immunotherapy can cure some cancers that until fairly recently were considered fatal. In addition to developing drugs that boost the immune system's cancer-fighting abilities, scientists are becoming expert at manipulating ...

Standard chemotherapy treatment for HPV-positive throat cancer remains the most effective, study finds

November 15, 2018
A new study funded by Cancer Research UK and led by the University of Birmingham has found that the standard chemotherapy used to treat a specific type of throat cancer remains the most effective.

Anti-malaria drugs have shown promise in treating cancer, and now researchers know why

November 15, 2018
Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers from the Abramson ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.